Lumibronze Mineral Spf 30 Bronzing Face Serum Liquid
NDC Package 87593-108-50

11-digit billing NDC: 87593010850

Package Information

Lumibronze Mineral Spf 30 Bronzing Face Serum liquids is iNDICATIONS USAGE SECTION. This formulation utilizes a liquid delivery system. Marketed by Lance (guangzhou) Biological Technology Co., Ltd., this product is identified by NDC 87593-108 and is authorized under FDA application M020.

Identification & Billing

NDC Package Code
87593-108-50
Package Description
50 g in 1 BOTTLE, GLASS
Product Code
11-Digit Billing Format
87593010850

Clinical Specifications

Proprietary Name
Lumibronze Mineral Spf 30 Bronzing Face Serum
Non-Proprietary Name
Lumibronze Mineral Spf 30 Bronzing Face Serum
Substance Name
Zinc Oxide; Titanium Dioxide
Dosage Form
Liquid - A dosage form consisting of a pure chemical in its liquid1 state. This dosage form term should not be applied to solutions.
Administration Route
Cutaneous - Administration to the skin.
Usage Information
INDICATIONS USAGE SECTION

Regulatory & Marketing

Labeler Name
Lance (guangzhou) Biological Technology Co., Ltd.
Product Type
Human Otc Drug
FDA Application #
M020
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
07-13-2026
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 87593-108-50 identifies a specific commercial package of 50 g in 1 bottle, glass of Lumibronze Mineral Spf 30 Bronzing Face Serum, a human over the counter drug labeled by Lance (guangzhou) Biological Technology Co., Ltd.. This liquid is formulated for cutaneous use and contains zinc oxide; titanium dioxide as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Lance (guangzhou) Biological Technology Co., Ltd. on July 13, 2026. The current certification is valid through December 31, 2027.

How is this Lance (guangzhou) Biological Technology Co., Ltd. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 87593010850. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
87593-108-50
11-Digit CMS (5-4-2)
87593-0108-50

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.